中华护理杂志 ›› 2022, Vol. 57 ›› Issue (2): 237-244.DOI: 10.3761/j.issn.0254-1769.2022.02.019
韦小夏(), 符鑫, 沈傲梅, 王玉洁, 张力川, 路潜()
收稿日期:
2021-07-20
出版日期:
2022-01-20
发布日期:
2022-01-20
通讯作者:
路潜,E-mail: luqian@bjmu.edu.cn作者简介:
韦小夏:女,本科(硕士在读),E-mail: weixiaoxia@bjmu.edu.cn
基金资助:
WEI Xiaoxia(), FU Xin, SHEN Aomei, WANG Yujie, ZHANG Lichuan, LU Qian()
Received:
2021-07-20
Online:
2022-01-20
Published:
2022-01-20
摘要:
目的 评价并总结乳腺癌患者淋巴水肿自我管理的相关证据,为临床医护人员指导患者进行自我管理,规范化评估患者自我管理状况提供依据。方法 系统检索国内外相关指南网站、专业协会网站以及PubMed、Web of Science、Embase、CINAHL、中国知网、维普、万方等数据库中关于乳腺癌患者淋巴水肿自我管理相关指南、专家共识、最佳实践和推荐实践等,检索时限为2011年1月1日—2021年5月31日。由2名研究者独立进行文献质量评价和资料提取。结果 共纳入24篇文献,其中指南7篇、专家共识6篇、最佳实践3篇、推荐实践8篇。从学习淋巴水肿相关知识、运动锻炼、保持健康体重、患肢保护、促进淋巴液回流、自我监测、心理调节、角色适应等8个方面汇总了28条最佳证据。结论 该研究总结了乳腺癌患者淋巴水肿自我管理的最佳证据,可为临床医护人员规范患者自我管理指导,动态评估患者自我管理状况提供依据。
韦小夏, 符鑫, 沈傲梅, 王玉洁, 张力川, 路潜. 乳腺癌患者淋巴水肿自我管理的证据总结[J]. 中华护理杂志, 2022, 57(2): 237-244.
WEI Xiaoxia, FU Xin, SHEN Aomei, WANG Yujie, ZHANG Lichuan, LU Qian. Evidence summary for self-management of lymphedema in breast cancer patients[J]. Chinese Journal of Nursing, 2022, 57(2): 237-244.
[1] |
Torgbenu E, Luckett T, Buhagiar MA, et al. Prevalence and incidence of cancer related lymphedema in low and middle-income countries:a systematic review and meta-analysis[J]. BMC Cancer, 2020, 20(1):604.
DOI PMID |
[2] | 刘飞, 路潜, 欧阳倩, 等. 乳腺癌患者术后淋巴水肿与其相关症状的关系研究[J]. 中华护理杂志, 2016, 51(5):518-522. |
Liu F, Lu Q, Ouyang Q, et al. The relationship between lymphedema status and lymphedema symptoms in breast cancer survivors[J]. Chin J Nurs, 2016, 51(5):518-522. | |
[3] | 尤渺宁, 康京京, 陆宇晗, 等. 乳腺癌相关淋巴水肿患者综合消肿治疗的居家护理[J]. 中华护理杂志, 2019, 54(8):1238-1240. |
You MN, Kang JJ, Lu YH, et al. Home nursing care of breast cancer-related lymphedema treated with complete decongestive therapy[J]. Chin J Nurs, 2019, 54(8):1238-1240. | |
[4] |
Temur K, Kapucu S. The effectiveness of lymphedema self-management in the prevention of breast cancer-related lymphedema and quality of life:a randomized controlled trial[J]. Eur J Oncol Nurs, 2019, 40:22-35.
DOI URL |
[5] |
Ridner SH, Fu MR, Wanchai A, et al. Self-management of lymphedema:a systematic review of the literature from 2004 to 2011[J]. Nurs Res, 2012, 61(4):291-299.
DOI URL |
[6] |
Armer JM, Ostby PL, Ginex PK, et al. ONS guidelinesTM for can-cer treatment-related lymphedema[J]. Oncol Nurs Forum, 2020, 47(5):518-538.
DOI PMID |
[7] |
Brouwers MC, Kho ME, Browman GP, et al. AGREE Ⅱ:advanc-ing guideline development,reporting,and evaluation in health care[J]. Prev Med, 2010, 51(5):421-424.
DOI PMID |
[8] | 胡雁, 郝玉芳. 循证护理学[M]. 2版. 北京: 人民卫生出版社, 2017: 31. |
Hu Y, Hao YF. Evidence-based nursing[M]. 2nd ed. Beijing: People’s Publishing House, 2017: 31. | |
[9] | 王春青, 胡雁. JBI证据预分级及证据推荐级别系统(2014版)[J]. 护士进修杂志, 2015, 30(11):964-967. |
Wang CQ, Hu Y. JBI evidence pre-classification and evidence rank system(2014 edition)[J]. J Nurses Train, 2015, 30(11):964-967. | |
[10] | The National Comprehensive Cancer Network (NCCN). The NCCN survivorship clinical practices guidelines in oncology(version 1.2021)[EB/OL].(2021-02-24)[2021-05-31].https://www.nccn.org/. |
[11] | The National Comprehensive Cancer Network (NCCN). Survivorship care for cancer-related late and long-term effects 2020[EB/OL].(2020-07-14)[2021-05-31]. https://www.nccn.org/patientresources/patient-resources. |
[12] |
Damstra RJ, Halk AB, Dutch Working Group on Lymphedema. The Dutch lymphedema guidelines based on the international classification of functioning,disability,and health and the chronic care model[J]. J Vasc Surg Venous Lymphat Disord, 2017, 5(5):756-765.
DOI PMID |
[13] | 王惠雪. 乳腺癌术后淋巴水肿预防行为临床实践指南初步构建[D]. 合肥:安徽医科大学, 2017. |
Wang HX. Primary establishment of clinical practice guideline for preventive behavior of breast cancer-related lymphedema[D]. Hefei:Anhui Medical University, 2017. | |
[14] | National Institute of Clinical Evidence (NICE). Advanced breast cancer:diagnosis and treatment[EB/OL].(2009-02-23)[2021-05-31].https://www.nice.org.uk/guidance/cg81/resources/advanced-breast-cancer-diagnosis-and-treatment-pdf-975683850181. |
[15] |
Gebruers N, Verbelen H, de Vrieze T, et al. Current and future perspectives on the evaluation,prevention and conservative management of breast cancer related lymphoedema:a best practice guideline[J]. Eur J Obstet Gynecol Reprod Biol, 2017, 216:245-253.
DOI PMID |
[16] | JBI. Breast cancer:lymphedema management[EB/OL].(2021-03-09)[2021-05-31]. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=jbi&NEWS=N&A-N=JBI1844. |
[17] | Australasian Lymphology Association. Lymphoedema management[EB/OL].(2021-01-01)[2021-05-31]. https://www.lympho-edema.org.au/about-lymphoedema/lymphoedema-management/. |
[18] | American Cancer Society. Lymphedema[EB/OL].(2021-05-25)[2021-05-31]. https://www.cancer.org/treat-ment/treatments-and-side-effects/physical-sideeffects/lymphedema.html. |
[19] | 中华护理学会. 护理团体标准解读:乳腺癌术后淋巴水肿预防和护理[EB/OL].(2021-03-13)[2021-05-31]. http://www.zhhlxh.org.cn/cnaWebcn/article/3245. |
Chinese Nursing Association. Prevention and nursing of lym-phedema after breast cancer surgery>[EB/OL].(2021-03-13)[2021-05-31]. http://www.zhhlxh.org.cn/cnaWebcn/article/3245. | |
[20] | UpToDate. Breast cancer-associated lymphedema[EB/OL].(2021-02-05)[2021-05-31].https://www.uptodate.com/contents/breast-cancer-associated-lymphedema. |
[21] | 中华整形外科学分会淋巴水肿学组. 外周淋巴水肿诊疗的中国专家共识[J]. 中华整形外科杂志, 2020, 36(4):355-360. |
Lymphedema Group,Chinese Society of Plastic Surgery. The Chinese consensus of the diagnosis and treatment of peripheral lymphedema[J]. Chin J Plast Surg, 2020, 36(4):355-360. | |
[22] | Executive Committee of the International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema:2020 consensus document of the international society of lymphology[J]. Lymphology, 2020, 53(1):3-19. |
[23] | 中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2019年版)[J]. 中国癌症杂志, 2019, 29(8):609-680. |
China Anti-Cancer Association, Committee of Breast Cancer Society. Guidelines and norms of breast cancer diagnosis and treatment of China Anti-Cancer Association(2019 edition)[J]. Chin Oncol, 2019, 29(8):609-680. | |
[24] | 河南省肿瘤医院乳腺癌诊疗共识专家团队. 河南省肿瘤医院乳腺癌相关继发性淋巴水肿诊疗专家共识[J]. 中华肿瘤防治杂志, 2019, 26(24):1855-1858. |
Expert team of breast cancer diagnosis and treatment consensus in Henan Cancer Hospital. Expert consensus on diagnosis and treatment of secondary lymphoedema in breast cancer in Henan Cancer Hospital[J]. Chin J Cancer Prev Treat, 2019, 26(24):1855-1858. | |
[25] | BMJ Best Practice. Lymphoedema-treatment algorithm[EB/OL].(2018-04-11)[2021-05-31]. https://bestpractice.bmj.com/topics/en-gb/610/treatment-algorithm. |
[26] |
McLaughlin SA, de Snyder SM, Klimberg S, et al. Considerations for clinicians in the diagnosis,prevention,and treatment of breast cancer-related lymphedema,recommendations from an expert panel:part 2:preventive and therapeutic options[J]. Ann Surg Oncol, 2017, 24(10):2827-2835.
DOI PMID |
[27] |
McLaughlin SA, Staley AC, Vicini F, et al. Considerations for clinicians in the diagnosis,prevention,and treatment of breast cancer-related lymphedema:recommendations from a multidisciplinary expert ASBrS panel:part 1:definitions,assessments,education,and future directions[J]. Ann Surg Oncol, 2017, 24(10):2818-2826.
DOI PMID |
[28] |
Ostby PL, Armer JM, Dale PS, et al. Surveillance recommendations in reducing risk of and optimally managing breast cancer-related lymphedema[J]. J Pers Med, 2014, 4(3):424-447.
DOI URL |
[29] | Cancer Australia. Lymphoedema—what you need to know[EB/OL].(2020-10-20)[2021-05-31]. https://www.canceraustralia.gov.au/affected-cancer/cancer-types/breastcancer/lymphoede-ma.can-cer/lymphoedema. |
[30] |
Armer JM, Hulett JM, Bernas M, et al. Best practice guidelines in assessment,risk reduction,management,and surveillance for post-breast cancer lymphedema[J]. Curr Breast Cancer Rep, 2013, 5(2):134-144.
PMID |
[31] | NLN Medical Advisory Committee. Position statement of the National Lymphedema Network[EB/OL].(2012)[2021-05-31]. https://lymphnet.org/position-papers. |
[32] | Lymphoedema Support Network. Reducing the risk of upper limb lymphoedema Guidance for nurses in acute and community settings[EB/OL].(2011-09-01)[2021-05-31]. https://www.lymphoedema.org/wpcontent/uploads/2020/01/reducing_the_risk_of_upper_limb_lymphoedema.pdf. |
[33] | 赵权萍, 李凤莲, 路潜. 乳腺癌患者术后淋巴水肿相关知识、危险因素及行为状况的研究[J]. 中华乳腺病杂志(电子版), 2019, 13(5):296-300. |
Zhao QP, Li FL, Lu Q. Investigation on postoperative lymphedema-related knowledge,risk factors and behaviors of breast cancer patients[J]. Chin J Breast Dis Electron Ed, 2019, 13(5):296-300. | |
[34] | 刘飞, 司龙妹, 王影新, 等. 乳腺癌相关淋巴水肿患者抗阻力训练的证据总结[J]. 中华护理杂志, 2021, 56(5):755-761. |
Liu F, Si LM, Wang YX, et al. Evidence summary of resista-nce training for breast cancer-related lymphedema[J]. Chin J Nurs, 2021, 56(5):755-761. | |
[35] |
Weiler MJ, Cribb MT, Nepiyushchikh Z, et al. A novel mouse tail lymphedema model for observing lymphatic pump failure during lymphedema development[J]. Sci Rep, 2019, 9(1):10405.
DOI URL |
[36] |
McLaughlin SA, Bagaria S, Gibson T, et al. Trends in risk reduction practices for the prevention of lymphedema in the first 12 months after breast cancer surgery[J]. J Am Coll Surg, 2013, 216(3):380-389.
DOI URL |
[37] | 刘宁飞. 淋巴水肿:诊断与治疗[M]. 北京: 科学出版社, 2014. |
Liu NF. Lymphedema-diagosis and treatment[M]. Beijing: Scie-nce Press, 2014. | |
[38] |
Fu MR, Ridner SH, Armer J. Post-breast cancer lymphedema:part 2[J]. Am J Nurs, 2009, 109(8):34-41.
DOI URL |
[39] | Lasinski BB, McKillip Thrift K, Squire D, et al. A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011[J]. PMR, 2012, 4(8):580-601. |
[40] |
Wei X, Lu Q, Jin S, et al. Developing and validating a prediction model for lymphedema detection in breast cancer survivors[J]. Eur J Oncol Nurs, 2021, 54:102023.
DOI URL |
[41] |
Ostby PL, Armer JM, Smith K, et al. Patient perceptions of bar-riers to self-management of breast cancer-related lymphedema[J]. West J Nurs Res, 2018, 40(12):1800-1817.
DOI URL |
[1] | 宋鹏娟, 刘均娥, 陈少华, 刘娟, 刘芳. 回归家庭干预对乳腺癌术后患者康复效果的影响[J]. 中华护理杂志, 2022, 57(2): 133-139. |
[2] | 高洪莲, 王春美, 王晓敏, 许丽娜, 王瑞知, 李书彦, 李滕, 李兴国. 非药物干预促进胃肠道恶性肿瘤患者术后功能恢复的最佳证据总结[J]. 中华护理杂志, 2022, 57(2): 215-222. |
[3] | 麦秋露, 王君鑫, 杨丹, 李学靖, 张小艳, 郝玉芳. 我国临床护理实践指南改编研究的范围综述[J]. 中华护理杂志, 2022, 57(1): 105-112. |
[4] | 李逗逗, 姚瑶, 曹琳, 郑仁东, 何志伟, 姚平, 王雅琳, 孙宇, 朱登月, 刘超. 专科护士主导的2型糖尿病患者共享门诊的构建及应用[J]. 中华护理杂志, 2022, 57(1): 17-22. |
[5] | 张晓娜, 李鑫丹, 芦鸿雁, 赵杰, 冯向侃. 出院准备服务对慢性阻塞性肺疾病患者干预效果的Meta分析[J]. 中华护理杂志, 2022, 57(1): 42-48. |
[6] | 杨雪凝, 李雪儿, 王松, 方紫妍, 柳静, Akimana Sandra, 张静. 慢性阻塞性肺疾病患者呼吸肌训练的最佳证据总结[J]. 中华护理杂志, 2022, 57(1): 49-55. |
[7] | 付子蔓, 王义婷, 蒲丛珊, 张莹莹, 张佳华, 单春剑. 男性对配偶围产期丧失体验的Meta整合[J]. 中华护理杂志, 2022, 57(1): 98-104. |
[8] | 李苗苗, 熊宇, 罗健. 炎症性肠病患者营养支持的最佳证据总结[J]. 中华护理杂志, 2021, 56(9): 1394-1400. |
[9] | 徐霓影, 任昕燕, 王茜茜, 沈睿, 盖家兴, 王俊杰. 痴呆患者进食困难管理的最佳证据总结[J]. 中华护理杂志, 2021, 56(9): 1401-1407. |
[10] | 吕永利,耿力,万盈璐,杨娇,胡莹,辛小燕,张可可. 子宫内膜癌患者术后下肢淋巴水肿风险预测模型的构建及效果验证[J]. 中华护理杂志, 2021, 56(8): 1174-1179. |
[11] | 文翠菊,王玥妮,孙红娟,于新颖. 芳香化酶抑制剂治疗期间乳腺癌患者症状群对生活质量的影响[J]. 中华护理杂志, 2021, 56(8): 1201-1207. |
[12] | 龚贝贝,米元元,韦彩云,黄海妹,吴金艳,玉明柳,刘宁梅,朱政. 肺结核患者规范化痰标本采集的最佳证据总结[J]. 中华护理杂志, 2021, 56(8): 1229-1235. |
[13] | 陶国芳,鲍杨娟,杨苏,邢美园,宋运莲,黄丽华. 慢性阻塞性肺疾病患者家庭氧疗管理的最佳证据总结[J]. 中华护理杂志, 2021, 56(7): 983-990. |
[14] | 中华护理学会内科专业委员会, 执笔:毛燕君, 张素, 张红梅. 含碘对比剂静脉外渗护理管理实践指南[J]. 中华护理杂志, 2021, 56(7): 1008-1008. |
[15] | 肖星婷,王娴,王燕,穆文方,朱为康. 乳腺癌患者化疗所致脱发预防及护理的证据总结[J]. 中华护理杂志, 2021, 56(7): 1072-1078. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||